Abstract
In the advanced stages of illness, patients often face challenging decisions regarding their treatment and overall medical care. Terminal ill patients are commonly affected by infections. However, in palliative care, the use of antimicrobials can be an ethical dilemma. Deciding whether to treat, withhold, or withdraw the antimicrobial treatment for an infection can be difficult. Antimicrobial administration can lead to adverse outcomes but the two main benefits, longer survival and symptom relief, are the main reasons why physicians prescribe antimicrobial when treating terminally ill patients. For the patient who has an irreversible advanced heart or lung disease, or an advanced dementia, or a metastatic cancer, it is easier the decision of withholding mechanical ventilation, tube feeding, and dialysis than antibiotherapy. To characterize infections, agents, and their treatments in palliative care, we conducted a review of the literature. We also included some tips to help health professionals to guide their clinical approach.
Similar content being viewed by others
References
World Health Organization (2002). National cancer control programmes: policies and managerial guidelines. http://apps.who.int/iris/bitstream/10665/42494/1/9241545577.pdf. Accessed 13 April 2016
DeVita V, Hellman S, Rosenberg S (2001). Cancer principles and practice of oncology, Sixth edition. Lippincott, Williams.
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730
Gaertner J, Weingärtner V, Wolf J, Voltz R (2013) Early palliative care for patients with advanced cancer: how to make it work? Curr Opin Oncol 25:342–352
Chochinov H (2002) Dignity-conserving care a new model for palliative care: helping the patient feel valued. JAMA 287:2253–2260
Schofield P, Carey M, Love A, Nehill C, Wein S (2006) ‘Would you like to talk about your future treatment options?’ discussing the transition from curative cancer treatment to palliative care. Palliat Med 20(4):397–406
Juthani-Mehta M, Malani P, Mitchell S (2015) Antimicrobials at the end of life: an opportunity to improve palliative care and infection management. JAMA 314(19):2017–2018
Ahronheim J, Morrison R, Baskin S, Morris J, Meier DE (1996) Treatment of the dying in the acute care hospital. Arch Intern Med 156:2094–2100
Goodlin S, Winzeberg G, Teno J et al (1998) Death in the hospital. Arch Intern Med 158:1570–1572
Pereira J, Watanabe S, Wolch G (1998) A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manag 16(6):374–381
Lagman R, Panta R, Walsh D (1996) Infectious complications in advanced cancer. Support Care Cancer 4:226
Nagy-Agren S, Haley H (2002) Management of infections in palliative care patients with advanced cancer. J Pain Symptom Manag 24(1):64–70
Glauser M, Zinner S (1982) Mechanisms of acquisition and development of bacterial infections in cancer patients. Raven Press, New York, pp 13–24
Vitetta L, Kenner D, Sali A (2000) Bacterial infections in terminally ill hospice patients. J Pain Symptom Manag 20(5):326–334
Marcus E, Clarfield A, Moses A (2001) Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis 33(10):1697–1705
Thompson A, Silveira M, Vitale C, Malani P (2012) Antimicrobial use at the end of life among hospitalized patients with advanced cancer. Am J Hosp Palliat Care 29(8):599–603
Albrecht J, McGregor J, Fromme E et al (2013) A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manag 46(4):483–490
Evers M, Purohit D, Perl D et al (2002) Palliative and aggressive end-of-life care for patients with dementia. Psychiatr Serv 53(5):609–613
Yao C, Hsieh M, Chiu T et al (2015) Wishes of patients with terminal cancer and influencing factors toward the use of antibiotics in Taiwan. Am J Hosp Palliat Care 32(5):537–543
White P, Kuhlenschmidt H, Vancura B, Navari R (2003) Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manag 25(5):438–443
Stiel S, Krumm N, Pestinger M, Lindena G, Nauck F, Ostgathe C, Radbruch L, Elsner F (2012) Antibiotics in palliative medicine-results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer 20(2):325–333
Clayton J, Fardell B, Hutton-Potts J, Webb D, Chye R (2003) Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med 17(1):44–48
Reinbolt R, Shenk A, White P, Navari R (2005) Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manag 30(2):175–182
Brown N, Thompson D (1979) Nontreatment of fever in extended-care facilities. N Engl J Med 300:1246–1250
Fabiszewski K, Volicer B, Volicer L (1990) Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients. JAMA 263:3168–3172
Chen L, Chou Y, Hsu P et al (2002) Antibiotic prescription for fever episodes in hospice patients. Support Care Cancer 10(7):538–541
Robinson G, Tegtmeier B, Zaia J (1984) Brief report: nosocomial infection rates in a cancer treatment center. Infect Control 5:289–294
Kuehn N, MacEachern T, Miller M, Spachynski K (1992) Nosocomial infections (NI) on a palliative care unit (PCU): a prospective comparison study. In: Poster for 9th international congress on Care of the Terminally ill. Canada, Montreal
Homsi J, Walsh D, Panta R et al (2000) Infectious complications of advanced cancer. Support Care Cancer 8(6):487–492
Beckers M, Ruven H, Seldenrijk C et al (2010) Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res 125(4):318–321
Narducci F, Jean-Laurent M, Boulanger L et al (2011) Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre. Eur J Surg Oncol 37(10):913–918
Becton D, Kletzel M, Golladay E et al (1988) An experience with an implanted port system in 66 children with cancer. Cancer 61(2):376–378
Winters V, Peters B, Coilá S, Jones L (1990) A trial with a new peripheral implanted vascular access device. Oncol Nurs Forum 17(6):891–896
McNelis J, Zarcone J, Marini C, Jurkiewicz A (2002) Outcome of subcutaneously implanted catheters in a teaching hospital. Am J Med Qual 17(5):185–188
Rotstein C, Cummings K, Nicolaou A et al (1988) Nosocomial infection rates at an oncology center. Infect Control Hosp Epidemiol 9(1):13–19
Bentley D, Bradley S, High K et al (2001) Practice guideline for evaluation of fever and infection in long-term care facilities. J Am Geriatr Soc 49(2):210–222
High K, Bradley S, Gravenstein S et al (2009) Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the infectious diseases society of America. Clin Infect Dis 48(2):149–171
McGeer A, Campbell B, Emori T et al (1991) Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 19:1–7
Yoshikawa TT, Norman DC (1987) Diagnostic approach to infections. Igaku-Shoin, New York, pp 26–31
Wasserman M, Levinstein M, Keller E et al (1989) Utility of fever, white blood cells, and differential count in predicting bacterial infections in the elderly. J Am Geriatr Soc 37:537–543
Nicolle LE (1993) Urinary tract infections in long-term care facilities. Infect Control Hosp Epidemiol 14:220–225
Muder R, Brennen C, Wagener M, Goetz A (1992) Bacteremia in a long-term care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis 14:647–654
Green K, Webster H, Watanabe S, Fainsinger R (1994) Management of nosocomial respiratory tract infections in terminally ill cancer patients. J Palliative Care 10(4):31–34
Bolayirli M, Turna H, Orhanoğlu T et al (2007) C-reactive protein as an acute phase protein in cancer patients. Med Oncol 24(3):338–344
Sedef A, Kose F, Mertsoylu H, Ozyilkan O (2015) Procalcitonin as a biomarker for infection-related mortality in cancer patients. Curr Opin Support Palliat Care 9(2):168–173
Shomali W, Hachem R, Chaftari A et al (2012) Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer 118(23):5823–5829
Miller D (1994) Withholding antibiotics as a form of care: an ethical perspective. Springer, New York, pp 283–298
MacKey J, Birchall I, MacDonald N (1995) Occult infection as a cause of hip pain in a patient with metastatic breast cancer. J Pain Symptom Manag 10(7):569–572
Reilly R, Teasdale T, McCullough L (1994) Projecting patients’ preferences from living wills: an invalid strategy for management of dementia with life-threatening illness. J Am Geriatr Soc 42:997–1003
Schrijvers D, Cherny N (2014) ESMO clinical practice guidelines on palliative care: advanced care planning. Ann Oncol 25(suppl 3):iii138–iii142
Hirsh J, Hoak J (1996) Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on thrombosis (in consultation with the council on cardiovascular radiology), American Heart Association. Circulation 93(12):2212–2245
Kröger K, Weiland D, Ose C et al (2006) Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 17(2):297–303
Stein P, Willis P, DeMets D et al (1981) History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. Am J Cardiol 47:218–223
Stein P, Afzal A, Henry J, Villareal C (2000) Fever in acute pulmonary embolism. Chest 117(1):39–42
Prigerson H, Bao Y, Shah M et al (2015) Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol 1(6):778–784
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Macedo, F., Nunes, C., Ladeira, K. et al. Antimicrobial therapy in palliative care: an overview. Support Care Cancer 26, 1361–1367 (2018). https://doi.org/10.1007/s00520-018-4090-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4090-8